- 如果您对该产品感兴趣的话，可以
- 产品名称：Anti-phospho-Rhodopsin (Ser334)抗体
- 产品型号：磷酸化视网膜色素变性蛋白4抗体
- 产品展商：KALANG
- 产品文档：无相关文档
- 发布时间：2018-07-17
- 在线询价
简单介绍
Anti-phospho-Rhodopsin (Ser334)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-phospho-Rhodopsin (Ser334)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
产品描述
Rabbit Anti-phospho-Rhodopsin (Ser334)
Cat. Number:
Anti-phospho-Rhodopsin (Ser334)抗体KL-19873R
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Retinitis pigmentosa is an inherited progressive disease which is a major cause of blindness in western communities. It can be inherited as an autosomal dominant, autosomal recessive, or X-linked recessive disorder. In the autosomal dominant form,which comprises about 25% of total cases, approximately 30% ofAnti-phospho-Rhodopsin (Ser334)抗体 families have mutations in the gene encoding the rod photoreceptor-specific protein rhodopsin. This is the transmembrane protein which, when photoexcited, initiates the visual transduction cascade. Defects in this gene are also one of the causes of congenital stationary night blindness. [provided by RefSeq, Jul 2008]
Also known as:
Rhodopsin (phospho S334); p-Rhodopsin (phospho S334); CSNBAD1; MGC138309; MGC138311; OPN 2; OPN2; opsd; OPSD_HUMAN; Anti-phospho-Rhodopsin (Ser334)抗体Opsin 2; opsin 2; Opsin 2 rod pigment; Opsin-2; Opsin2; Retinitis Pigmentosa 4; Retinitis pigmentosa 4 autosomal dominant; RHO; Rhodopsin; RP 4; RP4.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Rat, Rabbit, .
●
Immunogen: KLH conjugated synthesisedAnti-phospho-Rhodopsin (Ser334)抗体 phosphopeptide derived from human Rhodopsin around the phosphorylation site of Ser334..
●
Predicted Molecular Weight: 39kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-phospho-Rhodopsin (Ser334)抗体
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
